Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1402593

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1402593

Drug Abuse Treatment Market, By Abuse Type, By Drug Type, By Distribution Channel, By Region

PUBLISHED:
PAGES: 160 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

Global drug abuse treatment market is expected to reach US$ 20.70 Bn by 2030, from US$ 35.74 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 8.1% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 20.70 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 8.10% 2030 Value Projection: US$ 35.74 Bn
Figure 1. Global Drug Abuse Treatment Market Share (%), By Region, 2023
Drug Abuse Treatment Market - IMG1

Global drug abuse treatment market has been witnessing significant growth in the recent years. Rising prevalence of substance abuse disorders mainly due to easy availability of illicit drugs and growing mental health issues have necessitated effective treatment options. Moreover, increasing awareness about various pharmacological and psychological therapies for addiction treatment is driving more individuals to seek professional help. Various government initiatives promoting treatment programs along with growing health insurance coverage for substance abuse are also fueling the market expansion. However, social stigma associated with drug addiction continues to deter many patients from actively pursuing the available treatment options.

Market Dynamics:

Global drug abuse treatment market is primarily driven by growing substance abuse disorder prevalence worldwide. According to recent estimates, over 31 Mn people globally suffer from substance use disorders in 2023. Easy accessibility of drugs due to flourishing trafficking networks and rising social acceptance has resulted in higher consumption rates. Moreover, increasing mental health problems such as depression and anxiety often lead individuals towards substance dependency, thereby benefitting treatment providers. Various pharmacological and psychological therapies available for cocaine, alcohol, opioid, and cannabis addiction are also boosting the demand. However, financial constraints constitute a major restraint with outpatient rehab programs being costly for many patients. Lack of social support also acts as an impediment for successful recovery in a few regions. Nonetheless, government support through favorable regulations and public awareness campaigns present lucrative opportunities for sustained market growth.

Key features of the study:

  • This report provides in-depth analysis of the global drug abuse treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global drug abuse treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Cipla Limited, Glenmark Pharmaceuticals, Pfizer Inc., Mylan N.V., Odyssey Pharmaceuticals Inc., Lil' Drug Store Products Inc., Indivior Plc., Dr. Reddy's Laboratories, Teva Pharmaceutical Industries Ltd., and British American Tobacco Plc., Alkermes, Sun Pharmaceuticals, Dr. Reddy's Laboratories, BioCorRx, Inc., DXC Technology Company, and GenoLogics.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global drug abuse treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug abuse treatment market

Detailed Segmentation:

  • Global Drug Abuse Treatment Market, By Abuse Type
    • Alcohol Dependence
    • Tobacco/Nicotine Addiction
    • Opioid Addiction
  • Global Drug Abuse Treatment Market, By Drug Type
    • Disulfiram
    • Acamprosate
    • Naltrexone
    • Methadone
    • Buprenorphine
    • Nicotine Addiction Treatment
    • Nicotine Replacement Treatment
    • Nicotine Patch
    • Nicotine Gum
    • Nicotine Lozenge
    • Nicotine Spray
    • Nicotine Inhaler
    • Non-Nicotine Medication
    • Bupropion
    • Varenicline
    • Others
  • Global Drug Abuse Treatment Market, By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Drug Abuse Treatment Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa
  • Top Companies in Global Drug Abuse Treatment Market:
    • Cipla Limited
    • Glenmark Pharmaceuticals
    • Pfizer Inc.
    • Mylan N.V.
    • Odyssey Pharmaceuticals Inc.
    • Lil' Drug Store Products Inc.
    • Indivior Plc.
    • Reddy's Laboratories
    • Teva Pharmaceutical Industries Ltd.
    • British American Tobacco Plc.
    • Alkermes
    • Sun Pharmaceuticals
    • BioCorRx, Inc.
Product Code: CMI2011

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Abuse Type
    • Market Snippet, By Drug Type
    • Market Snippet, By Distribution Channel
    • Market Snippet ,By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Novel drug development
    • Social stigma associated with drug abuse
    • Strategic collaboration between market players
  • Key Highlights
  • Regulatory Scenario
  • Recent Trends
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Drug Abuse Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Drug Abuse Treatment Market, By Abuse Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Alcohol Dependence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Tobacco/Nicotine Addiction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Opioid Addiction
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Drug Abuse Treatment Market, By Drug Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Disulfiram
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Acamprosate
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Naltrexone
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Methadone
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Buprenorphine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Nicotine Addiction Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Nicotine Replacement Treatment
    • Nicotine Patch
    • Nicotine Gum
    • Nicotine Lozenge
    • Nicotine Spray
    • Nicotine Inhaler
  • Non-Nicotine Medication
    • Bupropion
    • Varenicline
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

7. Global Drug Abuse Treatment Market, By Distribution Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Drug Abuse Treatment Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2019 -2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
    • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Abuse Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030, (US$ Bn)
  • South Africa
  • North Africa
  • Central Africa

9. Competitive Landscape

  • Company Profile
    • Cipla Limited
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Glenmark Pharmaceuticals
    • Pfizer Inc.
    • Mylan N.V.
    • Odyssey Pharmaceuticals Inc.
    • Lil' Drug Store Products Inc.
    • Indivior Plc.
    • Reddy's Laboratories
    • Teva Pharmaceutical Industries Ltd.
    • British American Tobacco Plc.
    • Alkermes
    • Sun Pharmaceuticals
    • BioCorRx, Inc.
    • DXC Technology Company
    • GenoLogics
  • Analyst Views

10. Section

  • References
  • Research Methodology
  • About us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!